Patent classifications
G
PHYSICS
Load children
G01
MEASURING; TESTING
Load children
G01N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
Load children
2333/00
Assays involving biological materials from specific organisms or of a specific nature
Load children Filter patents View analytics View as hierarchy Open in page
G01N2333/906
acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
Load children Filter patents View analytics View as hierarchy Open in page
G01N2333/9065
acting on CH-NH groups of donors (1.5)
Load children Filter patents View analytics View as hierarchy Open in page
G01N2333/90672
with oxygen as acceptor (1.5.3) in general
Load children Filter patents View analytics View as hierarchy Open in page
G01N2333/90677
with a definite EC number (1.5.3.-)
Load children Filter patents View analytics View as hierarchy Open in page

G01N2333/90677

Systems and methods for sample preparation for enzymatic A1C detection and quantification
11634745 · 2023-04-25 · ·

A system for preparing a sample containing hemoglobin HbA1c for measurement by an electrochemical sensor includes a lysing formulary, the lysing formulary including a zwitterionic surfactant. The system further includes a oxidizing formulary, the oxidizing formulary including a cationic surfactant and a isothiazoline derivative and a protease formulary, the protease formulary including a molecule including an azole.

METHOD FOR THE IN VITRO DIAGNOSIS OF PROSTATE CANCER BY MEANS OF URINARY BIOMARKERS
20210270836 · 2021-09-02 ·

The present invention concerns a method for the in vitro/ex vivo diagnosis of a prostate cancer and/or the aggressiveness thereof by means of urinary biomarkers.

SYSTEMS AND METHODS FOR SAMPLE PREPARATION FOR ENZYMATIC A1C DETECTION AND QUANTIFICATION
20180251811 · 2018-09-06 ·

A system for preparing a sample containing hemoglobin HbA1c for measurement by an electrochemical sensor includes a lysing formulary, the lysing formulary including a zwitterionic surfactant. The system further includes a oxidizing formulary, the oxidizing formulary including a cationic surfactant and a isothiazoline derivative and a protease formulary, the protease formulary including a molecule including an azole.